Credit: Shutterstock photoVarian Medical Systems Inc ( VAR ) files its latest 10-K with SEC for the fiscal year ended on September 30, 2017. Varian Medical Systems Inc is engaged in the healthcare sector. It manufactures medical devices for conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Varian Medical Systems Inc has a market cap of $10.05 billion; its shares were traded at around $109.46 with a P/E ratio of 40.69 and P/S ratio of 2.98. Varian Medical Systems Inc had annual average EBITDA growth of 9.80% over the past ten years. GuruFocus rated Varian Medical Systems Inc the business predictability rank of 3-star .
For the last quarter Varian Medical Systems Inc reported a revenue of $739.0 million, compared with the revenue of $1.3 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $2.7 billion, a decrease of 17.1% from the previous year. For the last five years Varian Medical Systems Inc had an average revenue growth rate of 0.1% a year.
The reported diluted earnings per share was $2.68 for the year, a decline of 36% from the previous year. Over the last five years Varian Medical Systems Inc had an average EPS decline of 4.1% a year. The Varian Medical Systems Inc had a decent operating margin of 12.81%, compared with the operating margin of 17.12% a year before. The 10-year historical median operating margin of Varian Medical Systems Inc is 20.48%. The profitability rank of the company is 9 (out of 10).
At the end of the fiscal year, Varian Medical Systems Inc has the cash and cash equivalents of $716.2 million, compared with $843.5 million in the previous year. The company had no long term debt, compared with $287.5 million in the previous year. Varian Medical Systems Inc has a financial strength rank of 7 (out of 10).
At the current stock price of $109.46, Varian Medical Systems Inc is traded at 17.7% premium to its historical median P/S valuation band of $93.03 . The P/S ratio of the stock is 2.98, while the historical median P/S ratio is 2.55. The intrinsic value of the stock is $40.41 a share, according to GuruFocus DCF Calculator. The stock gained 34.19% during the past 12 months.
Directors and Officers Recent Trades:
- EVP and Pres. Oncology Sys. Kolleen T Kennedy sold 2,021 shares of VAR stock on 11/13/2017 at the average price of $107.36. The price of the stock has increased by 1.96% since.
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
